{"filing":{"accession_number":"0001193125-26-288390","cik":"0001136869","ticker":"ZBH","company_name":"ZIMMER BIOMET HOLDINGS, INC.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"d158696d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312526288390/d158696d8k.htm"},"events":[{"id":14594,"run_id":13003,"accession_number":"0001193125-26-288390","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Zimmer Biomet entered into two new revolving credit facilities totaling $2.75 billion ($1.5 billion five-year and $1.25 billion 364-day) on June 26, 2026, and terminated two prior 2025 credit agreements. This refinancing materially affects the company's capital structure and liquidity position.","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":12072,"accession_number":"0001193125-26-288390","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Zimmer Biomet entered into two new revolving credit facilities totaling $2.75 billion ($1.5 billion five-year and $1.25 billion 364-day) on June 26, 2026. This constitutes creation of new direct financial obligations under Item 1.01, fitting the debt_issuance category. The substantial size and multi-year nature of these credit arrangements would materially affect a reasonable investor's assessment of the company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"","ticker":null,"filing_date":""},{"id":12073,"accession_number":"0001193125-26-288390","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The filing discloses termination of two 2025 credit agreements in connection with entry into new Five-Year and 364-Day Credit Agreements. While Item 1.02 addresses termination, the material event is the refinancing and replacement of the credit facilities—a new direct financial obligation. The termination itself is routine (no outstanding principal, minimal fees), but the underlying refinancing activity is material to investors assessing the company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"","ticker":null,"filing_date":""},{"id":12074,"accession_number":"0001193125-26-288390","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation, and the disclosure is incorporated by reference from Item 1.01. This structure is typical for debt issuances, credit facility amendments, or similar financial obligations. Without access to Item 1.01 details, the Item 2.03 caption itself signals a debt or financing event material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12072,"accession_number":"0001193125-26-288390","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Zimmer Biomet entered into two new revolving credit facilities totaling $2.75 billion ($1.5 billion five-year and $1.25 billion 364-day) on June 26, 2026. This constitutes creation of new direct financial obligations under Item 1.01, fitting the debt_issuance category. The substantial size and multi-year nature of these credit arrangements would materially affect a reasonable investor's assessment of the company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-06-29"},{"id":12073,"accession_number":"0001193125-26-288390","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The filing discloses termination of two 2025 credit agreements in connection with entry into new Five-Year and 364-Day Credit Agreements. While Item 1.02 addresses termination, the material event is the refinancing and replacement of the credit facilities—a new direct financial obligation. The termination itself is routine (no outstanding principal, minimal fees), but the underlying refinancing activity is material to investors assessing the company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-06-29"},{"id":12074,"accession_number":"0001193125-26-288390","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation, and the disclosure is incorporated by reference from Item 1.01. This structure is typical for debt issuances, credit facility amendments, or similar financial obligations. Without access to Item 1.01 details, the Item 2.03 caption itself signals a debt or financing event material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:03:59.523909+00:00","company_name":"ZIMMER BIOMET HOLDINGS, INC.","ticker":"ZBH","filing_date":"2026-06-29"}]}